News
The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...
13h
Pharmaceutical Technology on MSNFDA approves Amneal’s DHE migraine/cluster headache autoinjectorThis makes Brekiya the first DHE autoinjector for treating these conditions. The autoinjector offers potential pain relief ...
Doesn't offer gap insurance. Limited network of local agents. Below average customer satisfaction for auto insurance claims in a recent J.D. Power study. GEICO earned 4.5 stars out of 5 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results